皮下注射針市場レポート：製品タイプ、用途、エンドユーザー、地域別、2025年～2033年

世界の皮下注射針の市場規模は2024年に31億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに53億米ドルに達し、2025年から2033年にかけて5.91%の成長率（CAGR）を示すと予測しています。同市場は、慢性疾患の罹患率の増加、予防接種や注射薬に対する需要の高まり、患者の快適性と安全性を高める画期的な注射針技術、新興国を中心とした世界の戦略的ヘルスケアインフラの拡大などを背景に大きな成長を遂げています。

皮下注射針市場分析：

主な市場促進要因：皮下注射針市場の成長は、注射薬を必要とする慢性疾患の有病率の上昇、ワクチンや治療薬に対する需要の増加、注射針の安全性と患者の快適性を高める技術の進歩、世界のヘルスケアインフラの拡大が大きく牽引しています。

主要市場動向：皮下注射針の市場動向には、針刺し損傷を最小限に抑えるための安全設計針の採用、患者の不快感を軽減するための細いゲージの針への嗜好の高まり、無痛ドラッグデリバリーのための無針注射システムの出現などが含まれます。

地理的動向：北米が皮下注射針市場で最大のシェアを占めているのは、医療制度が整備され、安全規制が厳しく、最新の注射針技術の採用率が高いためです。さらに、慢性疾患の増加や医療費の増加が、同地域が世界の医薬品市場をリードする原動力となっています。

競合情勢：皮下注射針業界の主要市場プレーヤーには、B. Braun Melsungen AG、Becton Dickinson and Company、Cardinal Health Inc.、Connecticut Hypodermics Inc.、EXELINT International Co.、Hi-Tech Syringes、McKesson Corporation、Medline Industries LP、Nipro Corporation、Retractable Technologies Inc.、Smiths Medical Inc.（ICU Medical Inc.）、Terumo Corporationなどがあります。

課題と機会：皮下注射針市場は、注射針の廃棄や環境への影響に関する懸念の高まり、ヘルスケア従事者の針刺し損傷、厳しい規制要件などの課題に直面しています。しかし、革新的な注射針技術の開発、新興国市場への開拓、アンメットニーズへの対応と患者ケアの向上を目指した研究開発のための共同開発などには機会が存在します。

皮下注射針市場動向：

継続的な医療の進歩が需要を牽引：

新しく高度な医療処置や医療の普及が皮下注射針市場の需要を高めています。例えば、米国疾病予防管理センター（CDC）によると、米国では年間約160億回の注射が行われており、現代医療における注射針の役割と重要性が示されています。これとは別に、予防接種プログラム、インスリン治療、その他の医療介入の増加は、人々の命を救うためにこれらの医療機器の不可欠な部分を示す皮下注射針の需要をエスカレートさせ、したがって、市場の成長を推進しています。世界の人口の高齢化に加え、慢性疾患により、注射器や注射針の需要を絶えず増加させるインスリンなどの薬を注射する必要性が高まっています。

慢性疾患の有病率の上昇：

糖尿病やがんなど、世界中の慢性疾患の数は日々拡大しています。世界保健機関（WHO）によると、非伝染性疾患は世界の主要な死因であり、これらの疾患は全死亡者の約60％を占めています。その結果、インスリンや化学療法薬などの薬を注射するために、皮下注射針や静脈注射針の常時供給が必要となります。さらに、慢性疾患患者管理のニーズの高まりによる生産量の増加に伴い、皮下注射針市場は大きな成長を遂げています。さらに、バイオテクノロジーにおける革新的なブレークスルーにより、注射薬の製造が増加し、皮下注射針の需要がエスカレートしています。

疾病予防のための政府の取り組み：

多くの国が、集団予防接種やHIV/AIDS予防対策など、疾病予防・対策に予算を割いています。例えば、国連持続可能な開発目標（UNSDGs）では、すべての年齢層を対象に健康と福祉の向上を掲げています。こうした取り組みの一環として、皮下注射針を中心とした予防接種プログラムが展開されており、こうした項目のニーズに応えています。各国政府が公衆衛生の課題にますます注力し、感染症対策にリソースを割くようになる中、無針注射器市場は、治療へのアクセスと治療結果の改善に向けたこうした協調的な取り組みにより、長期的に持続可能な成長を遂げるものと思われます。例えば、2020年の間に、世界保健機関（WHO）は、世界中の1億1,600万人の乳児がジフテリア破傷風百日咳（DTP）ワクチンを3回接種したことを示し、ワクチン接種の大きな可能性を実証しました。さらに、米国も同じ目的に貢献しています。

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界の皮下注射針市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：製品タイプ別

• セーフティ皮下注射針
• 非セーフティ皮下注射針

第7章 市場内訳：用途別

• ドラッグデリバリー
• 予防接種
• 血液検体採取

第8章 市場内訳：エンドユーザー別

• 病院と診療所
• 外来手術センター
• 糖尿病患者
• 家族診療
• 精神医学
• その他

第9章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋地域
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ
  • 市場内訳：国別

第10章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第13章 価格分析

第14章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • B. Braun Melsungen AG
  • Becton Dickinson and Company
  • Cardinal Health Inc.
  • Connecticut Hypodermics Inc.
  • EXELINT International Co.
  • Hi-Tech Syringes
  • McKesson Corporation
  • Medline Industries LP
  • Nipro Corporation
  • Retractable Technologies Inc.
  • Smiths Medical Inc.（ICU Medical Inc.）
  • Terumo Corporation

List of Figures

• Figure 1: Global: Hypodermic Needles Market: Major Drivers and Challenges
• Figure 2: Global: Hypodermic Needles Market: Sales Value (in Billion USD), 2019-2024
• Figure 3: Global: Hypodermic Needles Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 4: Global: Hypodermic Needles Market: Breakup by Product Type (in %), 2024
• Figure 5: Global: Hypodermic Needles Market: Breakup by Application (in %), 2024
• Figure 6: Global: Hypodermic Needles Market: Breakup by End User (in %), 2024
• Figure 7: Global: Hypodermic Needles Market: Breakup by Region (in %), 2024
• Figure 8: Global: Hypodermic Needles (Safety Hypodermic Needles) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 9: Global: Hypodermic Needles (Safety Hypodermic Needles) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 10: Global: Hypodermic Needles (Non-Safety Hypodermic Needles) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 11: Global: Hypodermic Needles (Non-Safety Hypodermic Needles) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 12: Global: Hypodermic Needles (Drug Delivery) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 13: Global: Hypodermic Needles (Drug Delivery) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 14: Global: Hypodermic Needles (Vaccination) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 15: Global: Hypodermic Needles (Vaccination) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 16: Global: Hypodermic Needles (Blood Specimen Collection) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 17: Global: Hypodermic Needles (Blood Specimen Collection) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 18: Global: Hypodermic Needles (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 19: Global: Hypodermic Needles (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 20: Global: Hypodermic Needles (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 21: Global: Hypodermic Needles (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 22: Global: Hypodermic Needles (Diabetic Patients) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 23: Global: Hypodermic Needles (Diabetic Patients) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 24: Global: Hypodermic Needles (Family Practices) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 25: Global: Hypodermic Needles (Family Practices) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 26: Global: Hypodermic Needles (Psychiatrics) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 27: Global: Hypodermic Needles (Psychiatrics) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 28: Global: Hypodermic Needles (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 29: Global: Hypodermic Needles (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 30: North America: Hypodermic Needles Market: Sales Value (in Million USD), 2019 & 2024
• Figure 31: North America: Hypodermic Needles Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 32: United States: Hypodermic Needles Market: Sales Value (in Million USD), 2019 & 2024
• Figure 33: United States: Hypodermic Needles Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 34: Canada: Hypodermic Needles Market: Sales Value (in Million USD), 2019 & 2024
• Figure 35: Canada: Hypodermic Needles Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 36: Asia-Pacific: Hypodermic Needles Market: Sales Value (in Million USD), 2019 & 2024
• Figure 37: Asia-Pacific: Hypodermic Needles Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 38: China: Hypodermic Needles Market: Sales Value (in Million USD), 2019 & 2024
• Figure 39: China: Hypodermic Needles Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 40: Japan: Hypodermic Needles Market: Sales Value (in Million USD), 2019 & 2024
• Figure 41: Japan: Hypodermic Needles Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 42: India: Hypodermic Needles Market: Sales Value (in Million USD), 2019 & 2024
• Figure 43: India: Hypodermic Needles Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 44: South Korea: Hypodermic Needles Market: Sales Value (in Million USD), 2019 & 2024
• Figure 45: South Korea: Hypodermic Needles Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 46: Australia: Hypodermic Needles Market: Sales Value (in Million USD), 2019 & 2024
• Figure 47: Australia: Hypodermic Needles Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 48: Indonesia: Hypodermic Needles Market: Sales Value (in Million USD), 2019 & 2024
• Figure 49: Indonesia: Hypodermic Needles Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 50: Others: Hypodermic Needles Market: Sales Value (in Million USD), 2019 & 2024
• Figure 51: Others: Hypodermic Needles Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 52: Europe: Hypodermic Needles Market: Sales Value (in Million USD), 2019 & 2024
• Figure 53: Europe: Hypodermic Needles Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 54: Germany: Hypodermic Needles Market: Sales Value (in Million USD), 2019 & 2024
• Figure 55: Germany: Hypodermic Needles Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 56: France: Hypodermic Needles Market: Sales Value (in Million USD), 2019 & 2024
• Figure 57: France: Hypodermic Needles Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 58: United Kingdom: Hypodermic Needles Market: Sales Value (in Million USD), 2019 & 2024
• Figure 59: United Kingdom: Hypodermic Needles Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 60: Italy: Hypodermic Needles Market: Sales Value (in Million USD), 2019 & 2024
• Figure 61: Italy: Hypodermic Needles Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 62: Spain: Hypodermic Needles Market: Sales Value (in Million USD), 2019 & 2024
• Figure 63: Spain: Hypodermic Needles Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 64: Russia: Hypodermic Needles Market: Sales Value (in Million USD), 2019 & 2024
• Figure 65: Russia: Hypodermic Needles Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 66: Others: Hypodermic Needles Market: Sales Value (in Million USD), 2019 & 2024
• Figure 67: Others: Hypodermic Needles Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 68: Latin America: Hypodermic Needles Market: Sales Value (in Million USD), 2019 & 2024
• Figure 69: Latin America: Hypodermic Needles Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 70: Brazil: Hypodermic Needles Market: Sales Value (in Million USD), 2019 & 2024
• Figure 71: Brazil: Hypodermic Needles Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 72: Mexico: Hypodermic Needles Market: Sales Value (in Million USD), 2019 & 2024
• Figure 73: Mexico: Hypodermic Needles Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 74: Others: Hypodermic Needles Market: Sales Value (in Million USD), 2019 & 2024
• Figure 75: Others: Hypodermic Needles Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 76: Middle East and Africa: Hypodermic Needles Market: Sales Value (in Million USD), 2019 & 2024
• Figure 77: Middle East and Africa: Hypodermic Needles Market: Breakup by Country (in %), 2024
• Figure 78: Middle East and Africa: Hypodermic Needles Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 79: Global: Hypodermic Needles Industry: SWOT Analysis
• Figure 80: Global: Hypodermic Needles Industry: Value Chain Analysis
• Figure 81: Global: Hypodermic Needles Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Hypodermic Needles Market: Key Industry Highlights, 2024 and 2033
• Table 2: Global: Hypodermic Needles Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
• Table 3: Global: Hypodermic Needles Market Forecast: Breakup by Application (in Million USD), 2025-2033
• Table 4: Global: Hypodermic Needles Market Forecast: Breakup by End User (in Million USD), 2025-2033
• Table 5: Global: Hypodermic Needles Market Forecast: Breakup by Region (in Million USD), 2025-2033
• Table 6: Global: Hypodermic Needles Market: Competitive Structure
• Table 7: Global: Hypodermic Needles Market: Key Players

The global hypodermic needles market size reached USD 3.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.3 Billion by 2033, exhibiting a growth rate (CAGR) of 5.91% during 2025-2033. The market is experiencing significant growth driven by increasing incidence of chronic diseases, rising demand for vaccinations and injectable medicines, needle breakthrough technologies that enhance comfort and safety for patients, and the expansion strategic healthcare infrastructure all over the world especially in the emerging economies.

Hypodermic Needles Market Analysis:

Major Market Drivers: The hypodermic needles market growth is significantly driven by the rising prevalence of chronic diseases requiring injectable medications, increasing demand for vaccines and therapeutic drugs, technological advancements enhancing needle safety and patient comfort, and expanding healthcare infrastructure globally.

Key Market Trends: The hypodermic needles market trends include the adoption of safety-engineered needles to minimize needlestick injuries, the growing preference for smaller gauge needles for reduced patient discomfort, and the emergence of needle-free injection systems for painless drug delivery.

Geographical Trends: North America has the largest share of the hypodermic needles market due to its a developed healthcare system, stringent safety regulations and a high adoption rate of the latest needle technologies. Moreover, the increasing numbers of chronic diseases and healthcare expenditure are driving the region to take the lead in the global pharmaceutical market.

Competitive Landscape: Some of the major market players in the hypodermic needles industry include B. Braun Melsungen AG, Becton Dickinson and Company, Cardinal Health Inc., Connecticut Hypodermics Inc., EXELINT International Co., Hi-Tech Syringes, McKesson Corporation, Medline Industries LP, Nipro Corporation, Retractable Technologies Inc., Smiths Medical Inc. (ICU Medical Inc.), Terumo Corporation, among many others.

Challenges and Opportunities: The hypodermic needles market faces challenges sich as rising concerns regarding needle disposal and environmental impact, needlestick injuries among healthcare workers, and stringent regulatory requirements. However, opportunities exist in the development of innovative needle technologies, expansion into emerging markets, and collaborations for research and development aimed at addressing unmet needs and improving patient care.

Hypodermic Needles Market Trends:

Ongoing Medical Advancements Driving Demand:

New and advanced medical procedures and the rising spread of health care has augmented the hypodermic needles market demand. For instance, the Centers for Disease Control and Prevention (CDC) stated that there are approximately 16 billion injections performed yearly in the United States indicating the role and importance of needles in modern medicine. Apart from this, the increase of vaccination programs, insulin therapy and other medical interventions has escalated the demand for hypodermic needles which show an integral part of these medical equipment in saving people's life, thus propelling the market growth. In addition to aging populations worldwide, chronic diseases have heightened the need of injecting medications such as insulin which constantly increase demand of syringes and needles.

Rising Prevalence of Chronic Diseases:

The number of chronic diseases from all over the world like diabetes and cancer is expanding every day. As per the World Health Organization (WHO), non-communicable diseases are the leading the cause of death in the world and these diseases are responsible for about 60% of all deaths. As a result, a constant supply of hypodermic or intravenous needles is required for injecting medications such as insulin and chemo drugs. Furthermore, with the increasing amount of production due to a growing need for chronically ill patient management, the hypodermic needles market is experiencing significant growth. Furthermore, the innovative breakthroughs in biotechnology result in more injectable medication manufacturing, escalating the demand for hypodermic needles escalates.

Government Initiatives for Disease Prevention:

Many countries are allocating their budgets to disease prevention and control measures, such as mass immunization and measures aimed at preventing HIV/AIDS. For instance, the UNSDGs that targets all ages to improve health and wellness. As part of these initiatives, vaccination programs with hypodermic needles as the central element are being deployed, meeting the need for these items. With governments increasingly focusing on the public health agenda and allocating resources to combat infectious diseases, the needle-free injector market is set to experience a long-term sustainable growth due to such concerted efforts at improving the access to and the outcome of care. For instance, during the year of 2020, the World Health Organization (WHO) indicated that 116 million infants across the globe received three doses of the diphtheria-tetanus-pertussis (DTP) vaccine demonstrating the significant potential of vaccination. Additionally, actions as the USA have contributed to the same cause.

Hypodermic Needles Market Segmentation:

Breakup by Product Type:

• Safety Hypodermic Needles
• Non-Safety Hypodermic Needles

Safety hypodermic needles accounts for the majority of the market share

Safety hypodermic needles can avoid needlestick injury and infection hazards among healthcare staff and patients. As stated by the Occupational Safety and Health Administration (OSHA), millions of healthcare workers around the world are affected by needlestick injuries every year. It is a significant issue mainly because of high-risk of contracting bloodborne diseases. The Occupational Safety and Health Administration (OSHA) indicated that implementing safety-engineered devices like retractable/shielded needles can help to widen the gap between these injuries. For instance, OSHA estimates that about 385 million needlestick injuries can be maybe prevented in the United States every year using safety engineered devices. While regulations enforcing safer working environment are adopting the use of safety hypodermic needles, this is likely going to increase, which will be a key factor in the subsequent market share for that product.

Breakup by Application:

• Drug Delivery
• Vaccination
• Blood Specimen Collection

In drug delivery, the rise of chronic diseases has escalated the need to have proper and accurate administration of medication which is directly contributing to hypodermic needles market demand. The progress of biotechnology and pharmaceuticals, and the invention of injectable types add to this high level of requests. There has been a rise in needle usage with vaccine programs worldwide mostly, due to the global push for inoculation against infectious diseases. The COVID-19 pandemic has heightened the significance of vaccination projects in public health prompting an increase of demand for hypodermic needles. Furthermore, blood sampling for diagnostic purposes is still the most important blood collection method in health facilities ensuring the consistent demand for hypodermic needles. These applications ensure the continued development of the hypodermic needles market.

Breakup by End User:

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Diabetic Patients
• Family Practices
• Psychiatrics
• Others

Hospitals and clinics represent the leading market segment

Hospitals and clinics propel the hypodermic needles market growth, having a key role in provision of health services. According to the American Hospital Association (AHA), the country had at least 6000 licensed hospitals operating in 2021, serving millions of patients over the years. Hypodermic needles in their turn are indispensable medical equipment that is used throughout numerous treatments and procedures carried out in hospitals and clinics, such as vaccinations, injections, blood drawings and diagnostics. As a result of aging population and the growing number of people with chronic diseases, the consumption of hypodermic needles in hospitals and clinics leads to the fact that these establishments are gaining hypodermic needles in large amounts. In addition, stringent infection control protocols established by government health agencies ensure quality and prevent the spreading of diseases in hospitals and in the clinics, environment guaranteeing patient safety and excellent healthcare results.

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

North America leads the market, accounting for the largest hypodermic needles market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for hypodermic needles.

North America remains the force of the hypodermic needles market as the region features a good healthcare infrastructure and the healthcare expenditure among the highest in the country generates a notable demand for medical devices, such as hypodermic needles. For instance, the Centers for Medicare & Medicaid Services (CMS), reported that healthcare expenditure in the United States reached $4.1 trillion in 2020, meaning that the nation has invested vast amount of money in health services and products. Besides, agencies like the Food and Drug Administration (FDA) impose stringent regulatory standards that ensure the effectiveness, reliability, and usability of hypodermic needles which are essential for healthcare providers and patients. Also, the region concentrates on medical devices that are both innovative and uses the latest healthcare practices which in turn boosts the use of hypodermic needles, thus placing North America as a market leader in the global hypodermic needles market.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the hypodermic needles industry include B. Braun Melsungen AG, Becton Dickinson and Company, Cardinal Health Inc., Connecticut Hypodermics Inc., EXELINT International Co., Hi-Tech Syringes, McKesson Corporation, Medline Industries LP, Nipro Corporation, Retractable Technologies Inc., Smiths Medical Inc. (ICU Medical Inc.) and Terumo Corporation.

Key Questions Answered in This Report

• 1.How big is the hypodermic needles market?
• 2.What is the future outlook of hypodermic needles market?
• 3.What are the key factors driving the hypodermic needles market?
• 4.Which region accounts for the largest hypodermic needles market share?
• 5.Which are the leading companies in the global hypodermic needles market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Hypodermic Needles Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product Type

• 6.1 Safety Hypodermic Needles
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Non-Safety Hypodermic Needles
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Application

• 7.1 Drug Delivery
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Vaccination
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Blood Specimen Collection
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals and Clinics
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Ambulatory Surgical Centers
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Diabetic Patients
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Family Practices
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Psychiatrics
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast
• 8.6 Others
  • 8.6.1 Market Trends
  • 8.6.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 B. Braun Melsungen AG
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 SWOT Analysis
  • 14.3.2 Becton Dickinson and Company
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
    • 14.3.2.4 SWOT Analysis
  • 14.3.3 Cardinal Health Inc.
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Connecticut Hypodermics Inc.
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 EXELINT International Co.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 Hi-Tech Syringes
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 McKesson Corporation
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Medline Industries LP
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 SWOT Analysis
  • 14.3.9 Nipro Corporation
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
    • 14.3.9.4 SWOT Analysis
  • 14.3.10 Retractable Technologies Inc.
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
  • 14.3.11 Smiths Medical Inc. (ICU Medical Inc.)
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 SWOT Analysis
  • 14.3.12 Terumo Corporation
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
    • 14.3.12.3 Financials
    • 14.3.12.4 SWOT Analysis